EXPERTS SEARCH

Applied Filters

Academic Degree Program
  • Post-Graduate Certificate in Precision Medicine

Profiles matching your search

Found 24 results
    • Associate Professor
    • Biochemistry and Molecular Genetics
    • Associate ProfessorBiochemistry and Molecular Genetics
    • Doctor of Dental Medicine (D.M.D.)
    • Post-Master's Doctor of Nurse Anesthesia Practice (D.N.A.P.)
    • Doctor of Osteopathic Medicine (D.O.)
    • Doctor of Optometry (O.D.)
    • Master of Medical Sciences in Physician Assistant Studies (M.M.S.)
    • Doctor of Podiatric Medicine (D.P.M.)
    • Master of Science in Precision Medicine (M.S.)
    • Post-Graduate Certificate in Precision Medicine
    • Glendale
    • Professor
    • Biochemistry and Molecular Genetics
    • ProfessorBiochemistry and Molecular Genetics
    Dr. Bjork received his Ph.D. from the University of Iowa in 2001. He completed his Postdoctoral Fellowship at Brigham & Women's Hospital/Harvard Medical School Division o Genetics in 2011. He began his teaching and independent research career at Midwestern University in 2011 as an Assistant Professor of Biochemistry. He earned Tenure in 2017 and was promoted to Associate Professor in Biochemistry and Molecular Genetics in 2018.
    Dr. Bjork received his Ph.D. from the University of Iowa in 2001. He completed his Postdoctoral Fellowship at Brigham & Women's Hospital/Harvard Medical School Division o Genetics in 2011. He began his teaching and independent research career at Midwestern University in 2011 as an Assistant Professor of Biochemistry. He earned Tenure in 2017 and was promoted to Associate Professor in Biochemistry and Molecular Genetics in 2018.
    • CDMI Student Research
    • IL-MABS Student Research
    • IL-MBS Student Research
    • Collaborative projects
    • Doctor of Dental Medicine (D.M.D.)
    • Doctor of Osteopathic Medicine (D.O.)
    • Master of Arts in Biomedical Sciences (M.A.)
    • Master of Biomedical Sciences (M.B.S.)
    • Master of Medical Sciences in Physician Assistant Studies (M.M.S.)
    • Doctor of Pharmacy (Pharm.D.)
    • Master of Science in Precision Medicine (M.S.)
    • Post-Graduate Certificate in Precision Medicine
    • Downers Grove
    • Associate Professor
    • Biochemistry and Molecular Genetics
    • Associate ProfessorBiochemistry and Molecular Genetics
    My laboratory focuses on the connections between cancer cell metabolism and regulation of gap junction communication. Gap junctions are regulated plasma membrane channels mediated by the connexin family of proteins. During early stages of cancer progression, gap junction communication is frequently lost due to decreased expression of connexin proteins or changes to subcellular transport. Loss of gap junction activity has been causatively linked to numerous cancer cell functions. However, this communication is dynamically regulated in cancer cells and can also be increased, particularly during the process of metastasis. This affects qualities including cellular invasion and adaptation to secondary metastatic sites. Additionally, changes to cancer cell energy utilization drive metabolic adaptability and induce therapeutic resistance. The goals of our laboratory are to understand the connections between metabolic pathways and regulation of connexin proteins which affect gap junction activity in the context of cancer.
    My laboratory focuses on the connections between cancer cell metabolism and regulation of gap junction communication. Gap junctions are regulated plasma membrane channels mediated by the connexin family of proteins. During early stages of cancer progression, gap junction communication is frequently lost due to decreased expression of connexin proteins or changes to subcellular transport. Loss of gap junction activity has been causatively linked to numerous cancer cell functions. However, this communication is dynamically regulated in cancer cells and can also be increased, particularly during the process of metastasis. This affects qualities including cellular invasion and adaptation to secondary metastatic sites. Additionally, changes to cancer cell energy utilization drive metabolic adaptability and induce therapeutic resistance. The goals of our laboratory are to understand the connections between metabolic pathways and regulation of connexin proteins which affect gap junction activity in the context of cancer.
    • Doctor of Osteopathic Medicine (D.O.)
    • Master of Arts in Biomedical Sciences (M.A.)
    • Master of Biomedical Sciences (M.B.S.)
    • Doctor of Pharmacy (Pharm.D.)
    • Master of Science in Precision Medicine (M.S.)
    • Post-Graduate Certificate in Precision Medicine
    • Doctor of Physical Therapy (D.P.T.)
    • Downers Grove
    • Professor
    • Biomedical Sciences
    • ProfessorBiomedical Sciences
    My lab team's overarching research goal is to elucidate mechanisms by which absence of the parkin protein causes a subset of human dopaminergic neurons to degenerate. Parkin loss-of-function Drosophilae are a particularly useful model in this context because the fruit fly has a brain region that is evolutionarily and functionally homologous to the brain structure that degenerates in Parkinson's disease patients. Parkin-null flies have selective degeneration in this region and subsequent motor deficits that are easily observed. We were the first to report deficits in a heterozygous parkin loss-of-function model. Using transgenic flies that facilitate visualization of mitochondria and autophagosomes in vulnerable fly neurons, we have reported significant differences in mitochondrial protein oxidation, morphology, and turnover in degenerating parkin-null fly neurons; these differences were not observed in similar but non-degenerating neurons. Our recent reports and current efforts are aimed at highlighting triggering sources of mitochondrial protein oxidation and testing novel Mn porphyrin antioxidants in our model.
    My lab team's overarching research goal is to elucidate mechanisms by which absence of the parkin protein causes a subset of human dopaminergic neurons to degenerate. Parkin loss-of-function Drosophilae are a particularly useful model in this context because the fruit fly has a brain region that is evolutionarily and functionally homologous to the brain structure that degenerates in Parkinson's disease patients. Parkin-null flies have selective degeneration in this region and subsequent motor deficits that are easily observed. We were the first to report deficits in a heterozygous parkin loss-of-function model. Using transgenic flies that facilitate visualization of mitochondria and autophagosomes in vulnerable fly neurons, we have reported significant differences in mitochondrial protein oxidation, morphology, and turnover in degenerating parkin-null fly neurons; these differences were not observed in similar but non-degenerating neurons. Our recent reports and current efforts are aimed at highlighting triggering sources of mitochondrial protein oxidation and testing novel Mn porphyrin antioxidants in our model.
    • Master of Science in Precision Medicine (M.S.)
    • Post-Graduate Certificate in Precision Medicine
    • Master of Arts in Biomedical Sciences (M.A.)
    • Master of Biomedical Sciences (M.B.S.)
    • Glendale
    • Associate Professor
    • Precision Medicine
    • Associate ProfessorPrecision Medicine

    Dr. Bussey is a cancer cytogeneticist, applied bioinformatician, and an associate professor in the Precision Medicine Program. She is passionate about educating healthcare professionals about genomics and how to integrate genomics into their current medical decision making. Her research centers around understanding how large-scale chromosome alterations in tumors lead to cancer. Her motivation, the observation that cancer is an evolutionary process characterized by chromosome evolution, has led her to interdisciplinary collaborations with engineers, theoretical physicists, and artists to study both common and rare cancers in academic, government, non-profit, and industry settings. An alumna of the University of Arizona, Dr. Bussey received her PhD in Medical and Molecular Genetics from Oregon Health and Science University in 2000 and completed a post-doctoral fellowship in bioinformatics at the National Cancer Institute. She has published 40+ scientific papers and has been granted six patents for her work, with an additional two patent applications pending.

     

    Patents:
    US 9,198,910: Methods for the Treatment of Cancer

    US 9,222,138: Therapeutic Targets for Adrenocortical Carcinoma

    US 9,745,634: Systems and Methods for Diagnosing and Treating Cancer

    US 10,066,270B2: Methods and Kits Used in Classifying Adrenocortical Carcinoma

    US 11,136,614: Live Cell Methods for Microarrays

    US 11,045,807: Integrated Platform for Characterization of Single Cells or Small Cell
    Clusters

    Dr. Bussey is a cancer cytogeneticist, applied bioinformatician, and an associate professor in the Precision Medicine Program. She is passionate about educating healthcare professionals about genomics and how to integrate genomics into their current medical decision making. Her research centers around understanding how large-scale chromosome alterations in tumors lead to cancer. Her motivation, the observation that cancer is an evolutionary process characterized by chromosome evolution, has led her to interdisciplinary collaborations with engineers, theoretical physicists, and artists to study both common and rare cancers in academic, government, non-profit, and industry settings. An alumna of the University of Arizona, Dr. Bussey received her PhD in Medical and Molecular Genetics from Oregon Health and Science University in 2000 and completed a post-doctoral fellowship in bioinformatics at the National Cancer Institute. She has published 40+ scientific papers and has been granted six patents for her work, with an additional two patent applications pending.

     

    Patents:
    US 9,198,910: Methods for the Treatment of Cancer

    US 9,222,138: Therapeutic Targets for Adrenocortical Carcinoma

    US 9,745,634: Systems and Methods for Diagnosing and Treating Cancer

    US 10,066,270B2: Methods and Kits Used in Classifying Adrenocortical Carcinoma

    US 11,136,614: Live Cell Methods for Microarrays

    US 11,045,807: Integrated Platform for Characterization of Single Cells or Small Cell
    Clusters

    • Master of Science in Precision Medicine (M.S.)
    • Post-Graduate Certificate in Precision Medicine
    • Glendale
    • Associate Professor
    • Chicago College of Optometry
    • Associate ProfessorChicago College of Optometry
    Dr. Fred Collison studied Biomedical Engineering at the University of Iowa, earning a Bachelor of Science in Engineering (BSE) degree. He then attended the Illinois College of Optometry, earning a Doctor of Optometry (OD) degree, and completed Residency training in Primary Care Optometry at the Cincinnati VA Medical Center. He completed Research Fellowship training in Hereditary Retinal Diseases at the Pangere Center for Inherited Retinal Diseases in The Chicago Lighthouse. His areas of both clinical and research expertise include inherited retinal diseases, and the testing procedures relevant to those conditions, such as electroretinography (ERG), optical coherence tomography (OCT) and psychophysical testing. He is also presently employed as Director of Clinical Electrophysiology at the Low Vision Clinic in The Chicago Lighthouse. He is a Fellow of the American Academy of Optometry and Board Certified by the American Board of Medical Optometry. Specialties: Visual Electrophysiology, Inherited Retinal Disease, Low Vision, Primary Care
    Dr. Fred Collison studied Biomedical Engineering at the University of Iowa, earning a Bachelor of Science in Engineering (BSE) degree. He then attended the Illinois College of Optometry, earning a Doctor of Optometry (OD) degree, and completed Residency training in Primary Care Optometry at the Cincinnati VA Medical Center. He completed Research Fellowship training in Hereditary Retinal Diseases at the Pangere Center for Inherited Retinal Diseases in The Chicago Lighthouse. His areas of both clinical and research expertise include inherited retinal diseases, and the testing procedures relevant to those conditions, such as electroretinography (ERG), optical coherence tomography (OCT) and psychophysical testing. He is also presently employed as Director of Clinical Electrophysiology at the Low Vision Clinic in The Chicago Lighthouse. He is a Fellow of the American Academy of Optometry and Board Certified by the American Board of Medical Optometry. Specialties: Visual Electrophysiology, Inherited Retinal Disease, Low Vision, Primary Care
    • Master of Science in Precision Medicine (M.S.)
    • Post-Graduate Certificate in Precision Medicine
    • Doctor of Optometry (O.D.)
    • Downers Grove
    • Assistant Professor
    • Precision Medicine
    • Assistant ProfessorPrecision Medicine
    • Master of Science in Precision Medicine (M.S.)
    • Post-Graduate Certificate in Precision Medicine
    • Downers Grove
    • Chair
    • Biochemistry and Molecular Genetics
    • ChairBiochemistry and Molecular Genetics
    • Doctor of Dental Medicine (D.M.D.)
    • Post-Master's Doctor of Nurse Anesthesia Practice (D.N.A.P.)
    • Doctor of Osteopathic Medicine (D.O.)
    • Master of Biomedical Sciences (M.B.S.)
    • Entry into Practice Doctor of Nurse Anesthesia Practice
    • Doctor of Optometry (O.D.)
    • Master of Medical Sciences in Physician Assistant Studies (M.M.S.)
    • Doctor of Podiatric Medicine (D.P.M.)
    • Doctor of Pharmacy (Pharm.D.)
    • Master of Science in Precision Medicine (M.S.)
    • Post-Graduate Certificate in Precision Medicine
    • Glendale
    • Associate Professor
    • Biochemistry and Molecular Genetics
    • Associate ProfessorBiochemistry and Molecular Genetics
    www.huynhlab.org
    www.huynhlab.org
    • Doctor of Dental Medicine (D.M.D.)
    • Doctor of Osteopathic Medicine (D.O.)
    • Entry into Practice Doctor of Nurse Anesthesia Practice
    • Doctor of Optometry (O.D.)
    • Master of Medical Sciences in Physician Assistant Studies (M.M.S.)
    • Doctor of Podiatric Medicine (D.P.M.)
    • Master of Science in Precision Medicine (M.S.)
    • Post-Graduate Certificate in Precision Medicine
    • Glendale
    • Program Director
    • Precision Medicine
    • Program DirectorPrecision Medicine
    Dr. Jentarra received her Ph.D. in Molecular and Cellular Biology from Arizona State University in 2004. She completed her Postdoctoral Fellowship in Developmental Neurogenetics at the Barrow Neurological Institute in Phoenix, Arizona in 2010 and continued there as a Research Associate studying Rett syndrome and other neurogenetic disorders until 2012. She began her teaching/research career at Midwestern University in 2012 in the Department of Biochemistry and Molecular Genetics. At Midwestern, Dr. Jentarra established her research program with several Rett Syndrome studies and later expanded into Alzheimer's disease research. Since then, her research at Midwestern has primarily been focused on Alzheimer's disease. In 2019, Dr. Jentarra was appointed the Program Director for the newly established Precision Medicine Program in the College of Graduate Studies at Midwestern. She guided the Program's development and oversaw its successful launch in June 2021. Since then she has both continued to direct the Program and has taught in many of it's courses.
    Dr. Jentarra received her Ph.D. in Molecular and Cellular Biology from Arizona State University in 2004. She completed her Postdoctoral Fellowship in Developmental Neurogenetics at the Barrow Neurological Institute in Phoenix, Arizona in 2010 and continued there as a Research Associate studying Rett syndrome and other neurogenetic disorders until 2012. She began her teaching/research career at Midwestern University in 2012 in the Department of Biochemistry and Molecular Genetics. At Midwestern, Dr. Jentarra established her research program with several Rett Syndrome studies and later expanded into Alzheimer's disease research. Since then, her research at Midwestern has primarily been focused on Alzheimer's disease. In 2019, Dr. Jentarra was appointed the Program Director for the newly established Precision Medicine Program in the College of Graduate Studies at Midwestern. She guided the Program's development and oversaw its successful launch in June 2021. Since then she has both continued to direct the Program and has taught in many of it's courses.
    • Doctor of Dental Medicine (D.M.D.)
    • Doctor of Osteopathic Medicine (D.O.)
    • Doctor of Optometry (O.D.)
    • Doctor of Podiatric Medicine (D.P.M.)
    • Doctor of Pharmacy (Pharm.D.)
    • Master of Science in Precision Medicine (M.S.)
    • Post-Graduate Certificate in Precision Medicine
    • Glendale
    • Professor
    • Anatomy
    • ProfessorAnatomy
    Dr. Jones received her PhD in Neuroscience from The Ohio State University in 2004 and joined Midwestern University as an Assistant Professor in 2008 (Department of Anatomy). She was promoted to Associate Professor with Tenure in 2013 and to Professor in 2019.
    Dr. Jones received her PhD in Neuroscience from The Ohio State University in 2004 and joined Midwestern University as an Assistant Professor in 2008 (Department of Anatomy). She was promoted to Associate Professor with Tenure in 2013 and to Professor in 2019.
    • Doctor of Dental Medicine (D.M.D.)
    • Doctor of Osteopathic Medicine (D.O.)
    • Doctor of Optometry (O.D.)
    • Doctor of Podiatric Medicine (D.P.M.)
    • Master of Science in Precision Medicine (M.S.)
    • Post-Graduate Certificate in Precision Medicine
    • Glendale
    • Associate Professor
    • Microbiology & Immunology
    • Associate ProfessorMicrobiology & Immunology
    • Doctor of Veterinary Medicine (D.V.M.)
    • Doctor of Osteopathic Medicine (D.O.)
    • Doctor of Podiatric Medicine (D.P.M.)
    • Doctor of Pharmacy (Pharm.D.)
    • Master of Science in Precision Medicine (M.S.)
    • Post-Graduate Certificate in Precision Medicine
    • Glendale
    • Associate Program Director
    • Biomedical Sciences
    • Associate Program DirectorBiomedical Sciences

    Dr. Kristjansdottir received her Ph.D. in Biochemistry from Duke University in Durham, North Carolina in 2005. She completed her Postdoctoral Fellowship at the The University of Chicago in 2011 and continued there as a Research Associate until 2012 studying alterations in phosphoproteomic signaling in several systems including the yeast cell cycle, tamoxifen resistance in breast cancer and the pediatric cancer, neuroblastoma . She joined Midwestern University in Downers Grove, IL in 2012 as an Assistant Professor in the Biomedical Sciences Program. She was promoted to Associate Professor with Tenure in 2017. In 2019, she became the Associate Program Director for the Precision Medicine Program in the College of Graduate Studies. Dr. Kristjansdottir was the President of the Chicago Mass Spectrometry Discussion Group (CMSDG) from 2016-2019. She is currently a member-at-large in the Society for In Vitro Biology and was Program Chair of the 2024 meeting. The Kristjansdottir lab focuses on molecular markers of neuroblastoma, and the molecular mechanism of topography directed nerve regeneration after injury.

    Dr. Kristjansdottir received her Ph.D. in Biochemistry from Duke University in Durham, North Carolina in 2005. She completed her Postdoctoral Fellowship at the The University of Chicago in 2011 and continued there as a Research Associate until 2012 studying alterations in phosphoproteomic signaling in several systems including the yeast cell cycle, tamoxifen resistance in breast cancer and the pediatric cancer, neuroblastoma . She joined Midwestern University in Downers Grove, IL in 2012 as an Assistant Professor in the Biomedical Sciences Program. She was promoted to Associate Professor with Tenure in 2017. In 2019, she became the Associate Program Director for the Precision Medicine Program in the College of Graduate Studies. Dr. Kristjansdottir was the President of the Chicago Mass Spectrometry Discussion Group (CMSDG) from 2016-2019. She is currently a member-at-large in the Society for In Vitro Biology and was Program Chair of the 2024 meeting. The Kristjansdottir lab focuses on molecular markers of neuroblastoma, and the molecular mechanism of topography directed nerve regeneration after injury.

    • IL-MBS Student Research
    • IL-MABS Student Research
    • Master of Arts in Biomedical Sciences (M.A.)
    • Master of Biomedical Sciences (M.B.S.)
    • Master of Science in Precision Medicine (M.S.)
    • Post-Graduate Certificate in Precision Medicine
    • Downers Grove
    • Associate Professor
    • Microbiology & Immunology
    • Associate ProfessorMicrobiology & Immunology
    Dr. Kronstad received her Ph.D in Microbiology from the University of Berkeley, California in 2013. She completed her postdoctoral fellowship at Stanford University in the Department of Medicine. She joined the faculty at Midwestern University in 2019 as an Assistant Professor.
    Dr. Kronstad received her Ph.D in Microbiology from the University of Berkeley, California in 2013. She completed her postdoctoral fellowship at Stanford University in the Department of Medicine. She joined the faculty at Midwestern University in 2019 as an Assistant Professor.
    • Doctor of Veterinary Medicine (D.V.M.)
    • Doctor of Dental Medicine (D.M.D.)
    • Doctor of Osteopathic Medicine (D.O.)
    • Master of Biomedical Sciences (M.B.S.)
    • Doctor of Optometry (O.D.)
    • Doctor of Podiatric Medicine (D.P.M.)
    • Doctor of Pharmacy (Pharm.D.)
    • Master of Science in Precision Medicine (M.S.)
    • Post-Graduate Certificate in Precision Medicine
    • Glendale
    • Assoc Dean Acad Affairs
    • College of Graduate Studies
    • Assoc Dean Acad AffairsCollege of Graduate Studies

    Dr. Leyva began her career teaching at Southwest College of Naturopathic Medicine and Health Sciences from 1996-1999. She joined the Microbiology & Immunology Department at MWU as an Assistant Professor in 1999, was promoted to Associate Professor in 2004, Professor in 2011, and became the Department Chair in 2018.

    Dr. Leyva began her career teaching at Southwest College of Naturopathic Medicine and Health Sciences from 1996-1999. She joined the Microbiology & Immunology Department at MWU as an Assistant Professor in 1999, was promoted to Associate Professor in 2004, Professor in 2011, and became the Department Chair in 2018.

    • Doctor of Veterinary Medicine (D.V.M.)
    • Doctor of Dental Medicine (D.M.D.)
    • Doctor of Osteopathic Medicine (D.O.)
    • Doctor of Optometry (O.D.)
    • Doctor of Pharmacy (Pharm.D.)
    • Master of Science in Precision Medicine (M.S.)
    • Post-Graduate Certificate in Precision Medicine
    • Glendale
    • Professor
    • Physiology
    • ProfessorPhysiology

    My research focuses on understanding the mechanisms that govern Ca²⁺ release from intracellular stores, namely the sarcoplasmic and endoplasmic reticulum (SR and ER), in excitable cells. Specifically, I seek to define how Ca²⁺ release units, formed by either ryanodine receptors (RyRs) or inositol 1,4,5-trisphosphate receptors (IP₃Rs), operate under the control of membrane Ca²⁺ channels (DHPRs) and/or receptor-activated signaling pathways.

    To address these questions, the functional properties of Ca²⁺ release events are investigated at the global (transients and waves), local (sparks and puffs), and molecular (single-channel) levels. These findings are interpreted in the context of cardiac excitation-contraction coupling and arrhythmogenic intracellular channelopathies.

    These studies employ a multidisciplinary experimental approach that integrates immunocytochemistry, electrophysiology, and advanced fluorescence microscopy, including line-scan confocal imaging of Ca²⁺ signals in single cells and pulsed local-field fluorescence imaging in intact, beating hearts. My long-term goal is to elucidate the molecular mechanisms underlying Ca²⁺ signaling in excitable cells and, in doing so, provide new insights into the local regulation of intracellular Ca²⁺ release channels.

    My research focuses on understanding the mechanisms that govern Ca²⁺ release from intracellular stores, namely the sarcoplasmic and endoplasmic reticulum (SR and ER), in excitable cells. Specifically, I seek to define how Ca²⁺ release units, formed by either ryanodine receptors (RyRs) or inositol 1,4,5-trisphosphate receptors (IP₃Rs), operate under the control of membrane Ca²⁺ channels (DHPRs) and/or receptor-activated signaling pathways.

    To address these questions, the functional properties of Ca²⁺ release events are investigated at the global (transients and waves), local (sparks and puffs), and molecular (single-channel) levels. These findings are interpreted in the context of cardiac excitation-contraction coupling and arrhythmogenic intracellular channelopathies.

    These studies employ a multidisciplinary experimental approach that integrates immunocytochemistry, electrophysiology, and advanced fluorescence microscopy, including line-scan confocal imaging of Ca²⁺ signals in single cells and pulsed local-field fluorescence imaging in intact, beating hearts. My long-term goal is to elucidate the molecular mechanisms underlying Ca²⁺ signaling in excitable cells and, in doing so, provide new insights into the local regulation of intracellular Ca²⁺ release channels.

    • Doctor of Dental Medicine (D.M.D.)
    • Doctor of Osteopathic Medicine (D.O.)
    • Master of Arts in Biomedical Sciences (M.A.)
    • Master of Biomedical Sciences (M.B.S.)
    • Doctor of Optometry (O.D.)
    • Master of Medical Sciences in Physician Assistant Studies (M.M.S.)
    • Master of Science in Cardiovascular Science (M.S.)
    • Doctor of Physical Therapy (D.P.T.)
    • Master of Science in Precision Medicine (M.S.)
    • Post-Graduate Certificate in Precision Medicine
    • Downers Grove
    • Associate Professor
    • Physiology
    • Associate ProfessorPhysiology
    We seek to elucidate the cellular and synaptic components that produce and modulate motor behaviours. We use the breathing circuit that controls the upper airway to address these research questions.
    We seek to elucidate the cellular and synaptic components that produce and modulate motor behaviours. We use the breathing circuit that controls the upper airway to address these research questions.
    • Doctor of Veterinary Medicine (D.V.M.)
    • Doctor of Osteopathic Medicine (D.O.)
    • Master of Science in Precision Medicine (M.S.)
    • Post-Graduate Certificate in Precision Medicine
    • Glendale
    • Associate Professor
    • Biochemistry and Molecular Genetics
    • Associate ProfessorBiochemistry and Molecular Genetics
    • Doctor of Dental Medicine (D.M.D.)
    • Doctor of Osteopathic Medicine (D.O.)
    • Doctor of Optometry (O.D.)
    • Doctor of Podiatric Medicine (D.P.M.)
    • Doctor of Pharmacy (Pharm.D.)
    • Master of Science in Precision Medicine (M.S.)
    • Post-Graduate Certificate in Precision Medicine
    • Glendale
    • Professor
    • Microbiology & Immunology
    • ProfessorMicrobiology & Immunology
    Dr. Michelle Swanson-Mungerson earned her Ph.D. in Immunology from Loyola University Stritch School of Medicine in 2002 followed by a post-doctoral fellowship at the Feinberg School of Medicine at Northwestern University until 2008. She then became a faculty member at Midwestern University where she teaches immunology and infectious disease to multiple programs. She is a National Faculty Member for the NBOME and contributes to the COMLEX and the Foundations of Biomedical Sciences COMAT. She is a member of the American Association of Immunology and serves on their Education Committee. She was awarded funding from the National Institutes of Health for her work in Epstein-Barr virus research, has published over 15 articles, and has been an invited speaker at national and international conferences.
    Dr. Michelle Swanson-Mungerson earned her Ph.D. in Immunology from Loyola University Stritch School of Medicine in 2002 followed by a post-doctoral fellowship at the Feinberg School of Medicine at Northwestern University until 2008. She then became a faculty member at Midwestern University where she teaches immunology and infectious disease to multiple programs. She is a National Faculty Member for the NBOME and contributes to the COMLEX and the Foundations of Biomedical Sciences COMAT. She is a member of the American Association of Immunology and serves on their Education Committee. She was awarded funding from the National Institutes of Health for her work in Epstein-Barr virus research, has published over 15 articles, and has been an invited speaker at national and international conferences.
    • IL-MABS Student Research
    • IL-MBS Student Research
    • CCOM Student Research
    • CDMI Student Research
    • Doctor of Dental Medicine (D.M.D.)
    • Doctor of Osteopathic Medicine (D.O.)
    • Master of Arts in Biomedical Sciences (M.A.)
    • Master of Biomedical Sciences (M.B.S.)
    • Doctor of Optometry (O.D.)
    • Doctor of Pharmacy (Pharm.D.)
    • Master of Science in Precision Medicine (M.S.)
    • Post-Graduate Certificate in Precision Medicine
    • Downers Grove
    • Associate Professor
    • Microbiology & Immunology
    • Associate ProfessorMicrobiology & Immunology
    Dr. Julie Swartzendruber earned her Ph.D. from Northwestern University in 2013 where she studied the role of histamine 2 receptor in allergic lung inflammation. She continued her training as a post-doctoral fellow at Loyola University of Chicago, studying the role of the probiotic Bacillus subtilis in suppressing allergic airway disease. Dr. Swartzendruber came to Midwestern University in 2015 and her research laboratory continues to study both projects; 1) The ability of B. subtilis to suppress allergic disease and 2) The influence of histamine receptor expression on the inflammatory process.
    Dr. Julie Swartzendruber earned her Ph.D. from Northwestern University in 2013 where she studied the role of histamine 2 receptor in allergic lung inflammation. She continued her training as a post-doctoral fellow at Loyola University of Chicago, studying the role of the probiotic Bacillus subtilis in suppressing allergic airway disease. Dr. Swartzendruber came to Midwestern University in 2015 and her research laboratory continues to study both projects; 1) The ability of B. subtilis to suppress allergic disease and 2) The influence of histamine receptor expression on the inflammatory process.
    • CCOM Student Research
    • CDMI Student Research
    • IL-MABS Student Research
    • IL-MBS Student Research
    • Doctor of Dental Medicine (D.M.D.)
    • Doctor of Osteopathic Medicine (D.O.)
    • Doctor of Optometry (O.D.)
    • Master of Medical Sciences in Physician Assistant Studies (M.M.S.)
    • Master of Science in Precision Medicine (M.S.)
    • Post-Graduate Certificate in Precision Medicine
    • Downers Grove
    • Assistant Professor
    • Microbiology & Immunology
    • Assistant ProfessorMicrobiology & Immunology
    Principal investigator and instructor driven to develop our understanding of the evolution of virulence factors, selective pressures on these factors, and their underlying regulatory mechanisms. As a PI, my research seeks to identify gaps in our collective knowledge in these fields using a combination of traditional bench top and biochemical techniques while selectively applying 'omics techniques to delve further into their underlying mechanisms. Currently my research is centered on identification of arthropod (e.g. mosquitos, brine shrimp) virulence factors and their expression by Chromobacterium spp. As an instructor I am fueled by my student's sympathy laughs as I strive to integrate seminal research from the golden age of microbiology and discuss of the forces of selection and evolution on biological mechanisms.
    Principal investigator and instructor driven to develop our understanding of the evolution of virulence factors, selective pressures on these factors, and their underlying regulatory mechanisms. As a PI, my research seeks to identify gaps in our collective knowledge in these fields using a combination of traditional bench top and biochemical techniques while selectively applying 'omics techniques to delve further into their underlying mechanisms. Currently my research is centered on identification of arthropod (e.g. mosquitos, brine shrimp) virulence factors and their expression by Chromobacterium spp. As an instructor I am fueled by my student's sympathy laughs as I strive to integrate seminal research from the golden age of microbiology and discuss of the forces of selection and evolution on biological mechanisms.
    • Doctor of Osteopathic Medicine (D.O.)
    • Master of Arts in Biomedical Sciences (M.A.)
    • Master of Biomedical Sciences (M.B.S.)
    • Doctor of Optometry (O.D.)
    • Master of Medical Sciences in Physician Assistant Studies (M.M.S.)
    • Master of Science in Precision Medicine (M.S.)
    • Post-Graduate Certificate in Precision Medicine
    • Downers Grove
    • Associate Professor
    • Precision Medicine
    • Associate ProfessorPrecision Medicine
    • IL-MBS Student Research
    • CCOM Student Research
    • CDMI Student Research
    • IL-MABS Student Research
    • Master of Science in Precision Medicine (M.S.)
    • Post-Graduate Certificate in Precision Medicine
    • Downers Grove
    • Associate Professor
    • Biomedical Sciences
    • Associate ProfessorBiomedical Sciences
    Dr. Wellensiek received his Ph.D. from the University of Arizona, and completed his postdoctoral work at the Biodesign Institute at Arizona State University. His research focuses on understanding non-traditional protein translation and how this mechanism contributes to the overall protein diversity found in eukaryotic cells. Furthermore, his laboratory is exploring how to use genomic sequences called translation enhancing elements to improve vaccinia virus-based and mRNA-based vaccines.
    Dr. Wellensiek received his Ph.D. from the University of Arizona, and completed his postdoctoral work at the Biodesign Institute at Arizona State University. His research focuses on understanding non-traditional protein translation and how this mechanism contributes to the overall protein diversity found in eukaryotic cells. Furthermore, his laboratory is exploring how to use genomic sequences called translation enhancing elements to improve vaccinia virus-based and mRNA-based vaccines.
    • Master of Arts in Biomedical Sciences (M.A.)
    • Master of Biomedical Sciences (M.B.S.)
    • Master of Science in Precision Medicine (M.S.)
    • Post-Graduate Certificate in Precision Medicine
    • Glendale
    • Vice President and Chief Academic Officer
    • University Administration
    • Vice President and Chief Academic OfficerUniversity Administration
    • Doctor of Osteopathic Medicine (D.O.)
    • Master of Arts in Biomedical Sciences (M.A.)
    • Master of Biomedical Sciences (M.B.S.)
    • Master of Public Health (M.P.H.)
    • Doctor of Podiatric Medicine (D.P.M.)
    • Master of Science in Precision Medicine (M.S.)
    • Post-Graduate Certificate in Precision Medicine
    • Glendale